Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 11
2004 11
2005 5
2006 6
2007 5
2008 3
2009 5
2010 5
2011 7
2012 4
2013 11
2014 10
2015 12
2016 7
2017 9
2018 6
2019 8
2020 8
2021 9
2022 11
2023 12
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

156 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study.
Gonzales E, Hardikar W, Stormon M, Baker A, Hierro L, Gliwicz D, Lacaille F, Lachaux A, Sturm E, Setchell KDR, Kennedy C, Dorenbaum A, Steinmetz J, Desai NK, Wardle AJ, Garner W, Vig P, Jaecklin T, Sokal EM, Jacquemin E. Gonzales E, et al. Among authors: setchell kdr. Lancet. 2021 Oct 30;398(10311):1581-1592. doi: 10.1016/S0140-6736(21)01256-3. Epub 2021 Oct 28. Lancet. 2021. PMID: 34755627 Clinical Trial.
Inborn Errors of Bile Acid Metabolism.
Heubi JE, Setchell KDR, Bove KE. Heubi JE, et al. Among authors: setchell kdr. Clin Liver Dis. 2018 Nov;22(4):671-687. doi: 10.1016/j.cld.2018.06.006. Epub 2018 Aug 22. Clin Liver Dis. 2018. PMID: 30266156 Review.
Upregulation of acid ceramidase contributes to tumor progression in tuberous sclerosis complex.
Astrinidis A, Li C, Zhang EY, Zhao X, Zhao S, Guo M, Olatoke T, Mattam U, Huang R, Zhang AG, Pitstick L, Kopras EJ, Gupta N, Jandarov R, Smith EP, Fugate E, Lindquist D, Markiewski MM, Karbowniczek M, Wikenheiser-Brokamp KA, Setchell KDR, McCormack FX, Xu Y, Yu JJ. Astrinidis A, et al. Among authors: setchell kdr. JCI Insight. 2023 May 8;8(9):e166850. doi: 10.1172/jci.insight.166850. JCI Insight. 2023. PMID: 36927688 Free PMC article.
Equol: pharmacokinetics and biological actions.
Setchell KD, Clerici C. Setchell KD, et al. J Nutr. 2010 Jul;140(7):1363S-8S. doi: 10.3945/jn.109.119784. Epub 2010 Jun 2. J Nutr. 2010. PMID: 20519411 Free PMC article. Review.
Equol: history, chemistry, and formation.
Setchell KD, Clerici C. Setchell KD, et al. J Nutr. 2010 Jul;140(7):1355S-62S. doi: 10.3945/jn.109.119776. Epub 2010 Jun 2. J Nutr. 2010. PMID: 20519412 Free PMC article. Review.
Maralixibat for the treatment of PFIC: Long-term, IBAT inhibition in an open-label, Phase 2 study.
Loomes KM, Squires RH, Kelly D, Rajwal S, Soufi N, Lachaux A, Jankowska I, Mack C, Setchell KDR, Karthikeyan P, Kennedy C, Dorenbaum A, Desai NK, Garner W, Jaecklin T, Vig P, Miethke A, Thompson RJ. Loomes KM, et al. Among authors: setchell kdr. Hepatol Commun. 2022 Sep;6(9):2379-2390. doi: 10.1002/hep4.1980. Epub 2022 May 4. Hepatol Commun. 2022. PMID: 35507739 Free PMC article. Clinical Trial.
Farnesoid X receptor antagonizes macrophage-dependent licensing of effector T lymphocytes and progression of sclerosing cholangitis.
Shi T, Malik A, Yang Vom Hofe A, Matuschek L, Mullen M, Lages CS, Kudira R, Singh R, Zhang W, Setchell KDR, Hildeman D, Pasare C, Wagner B, Miethke AG. Shi T, et al. Among authors: setchell kdr. Sci Transl Med. 2022 Dec 14;14(675):eabi4354. doi: 10.1126/scitranslmed.abi4354. Epub 2022 Dec 14. Sci Transl Med. 2022. PMID: 36516265 Free PMC article.
Inborn errors of bile acid metabolism.
Heubi JE, Setchell KD, Bove KE. Heubi JE, et al. Among authors: setchell kd. Semin Liver Dis. 2007 Aug;27(3):282-94. doi: 10.1055/s-2007-985073. Semin Liver Dis. 2007. PMID: 17682975 Review.
156 results